DK0863866T3 - Butyrat-prodrugs afledt af mælkesyre - Google Patents

Butyrat-prodrugs afledt af mælkesyre

Info

Publication number
DK0863866T3
DK0863866T3 DK96933967T DK96933967T DK0863866T3 DK 0863866 T3 DK0863866 T3 DK 0863866T3 DK 96933967 T DK96933967 T DK 96933967T DK 96933967 T DK96933967 T DK 96933967T DK 0863866 T3 DK0863866 T3 DK 0863866T3
Authority
DK
Denmark
Prior art keywords
lactic acid
methods
agents
alone
combination
Prior art date
Application number
DK96933967T
Other languages
Danish (da)
English (en)
Inventor
Biqin Li
Roger D Tung
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/540,345 external-priority patent/US5883123A/en
Priority claimed from US08/640,260 external-priority patent/US5912269A/en
Application filed by Vertex Pharma filed Critical Vertex Pharma
Application granted granted Critical
Publication of DK0863866T3 publication Critical patent/DK0863866T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C07C69/68—Lactic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96933967T 1995-10-06 1996-09-30 Butyrat-prodrugs afledt af mælkesyre DK0863866T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/540,345 US5883123A (en) 1995-10-06 1995-10-06 Butyrate prodrugs derived from lactic acid
US08/640,260 US5912269A (en) 1996-04-30 1996-04-30 Butyrate prodrugs derived from lactic acid
PCT/US1996/015660 WO1997012855A1 (en) 1995-10-06 1996-09-30 Butyrate prodrugs of lactic acid

Publications (1)

Publication Number Publication Date
DK0863866T3 true DK0863866T3 (da) 2001-06-11

Family

ID=27066414

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96933967T DK0863866T3 (da) 1995-10-06 1996-09-30 Butyrat-prodrugs afledt af mælkesyre

Country Status (19)

Country Link
EP (1) EP0863866B1 (zh)
JP (1) JPH11512743A (zh)
KR (1) KR19990063988A (zh)
CN (1) CN1201447A (zh)
AT (1) ATE200893T1 (zh)
AU (1) AU718983B2 (zh)
BR (1) BR9610850A (zh)
CA (1) CA2233606A1 (zh)
DE (1) DE69612671T2 (zh)
DK (1) DK0863866T3 (zh)
ES (1) ES2158351T3 (zh)
GR (1) GR3035899T3 (zh)
HK (1) HK1016153A1 (zh)
IN (1) IN181999B (zh)
NZ (1) NZ319877A (zh)
PT (1) PT863866E (zh)
RU (1) RU2175967C2 (zh)
TW (1) TW422834B (zh)
WO (1) WO1997012855A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880152A (en) * 1995-10-06 1999-03-09 Vertex Pharmaceuticals, Inc. Butyrate prodrugs derived from lactic acid
US6225350B1 (en) 1998-03-10 2001-05-01 Vertex Pharmaceuticals, Inc. Butyrate prodrugs derived from lactic acid
US6878361B2 (en) 2001-07-10 2005-04-12 Battelle Memorial Institute Production of stable aqueous dispersions of carbon nanotubes
US6896864B2 (en) 2001-07-10 2005-05-24 Battelle Memorial Institute Spatial localization of dispersed single walled carbon nanotubes into useful structures
EP1449535B1 (en) * 2003-02-18 2006-05-03 Clinique La Prairie Research SA Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
WO2005011696A1 (en) * 2003-08-01 2005-02-10 Fibrogen, Inc. Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE277700C (zh) *
DE824041C (de) * 1945-10-22 1951-12-10 Howards & Sons Ltd Verfahren zur Herstellung von aliphatischen a -Acyloxymonocarbonsaeuren
GB603189A (en) * 1945-10-22 1948-06-10 Howards & Sons Ltd Manufacture of acyloxy-carboxylic acids
US2464992A (en) * 1946-10-10 1949-03-22 Chessie E Rehberg Esters of acyloxycarboxylic acids
FR1578064A (zh) * 1968-05-20 1969-08-14
NL9200481A (nl) * 1992-03-13 1993-10-01 Univ Groningen Farmaceutisch preparaat met plaatsgerichte afgifte.
JPH08113795A (ja) * 1994-10-14 1996-05-07 T Hasegawa Co Ltd 香料組成物

Also Published As

Publication number Publication date
CA2233606A1 (en) 1997-04-10
HK1016153A1 (en) 1999-10-29
BR9610850A (pt) 1999-07-13
KR19990063988A (ko) 1999-07-26
TW422834B (en) 2001-02-21
RU2175967C2 (ru) 2001-11-20
PT863866E (pt) 2001-09-28
JPH11512743A (ja) 1999-11-02
IN181999B (zh) 1998-11-28
CN1201447A (zh) 1998-12-09
ES2158351T3 (es) 2001-09-01
ATE200893T1 (de) 2001-05-15
DE69612671T2 (de) 2004-08-05
EP0863866A1 (en) 1998-09-16
WO1997012855A1 (en) 1997-04-10
DE69612671D1 (de) 2001-06-07
GR3035899T3 (en) 2001-08-31
EP0863866B1 (en) 2001-05-02
AU718983B2 (en) 2000-05-04
NZ319877A (en) 1999-09-29
AU7249896A (en) 1997-04-28

Similar Documents

Publication Publication Date Title
TR200000481T2 (tr) N-Alkonoilfenilalenin türevleri.
TR200101124T2 (tr) N-(2-aril-propiyonil)-sülfonamidler ve bunları içeren farmasötik preparasyonlar.
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
EG23729A (en) N-alkanoylphenylalanine derivatives
ATE215924T1 (de) Lipoxinverbindungen und deren verwendung zur behandlung der zellenwucherungsstörung
ATE229533T1 (de) Nitrat-salze als arzneimittel
FI962591A (fi) Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä
ATE319712T1 (de) Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
PT809437E (pt) Tiois para promover crescimento de celulas progenitoras hematopoieticas
DE69635670D1 (de) Threitol-buttersäureester-enthaltende zusammensetzungen und ihre verwendung
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
ATE223214T1 (de) Von milchsäure abgeleitete butyrat-prodrugs
DK0863866T3 (da) Butyrat-prodrugs afledt af mælkesyre
MXPA94001321A (es) Funcion y actividad de la proteina viral r.
ATE267816T1 (de) Tan-1057 derivate
TR199801732T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
DE69803383D1 (de) Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
NO20006699L (no) Forbindelser med veksthormonfrigjörende egenskaper
MX9700854A (es) Derivados de azabicicloheptano n-substituidos utiles como neurolepticos.
ATE345809T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
MXPA02003731A (es) Derivados novedosos de acido fusidico.
MX9700360A (es) Dinoclesido-5, 5 -pirofosfatos.